A phase II trial of weekly irinotecan in cisplatin-refractory esophageal cancer.
Year: 2007
Type: article
Study design: Clinical Trial
Source: PubMed
Authors: Christof Burkart, Carsten Bokemeyer, Bodo Klump, Philippe Pereira, Reinhard Teichmann, Jörg Thomas Hartmann
Institution: University of Tübingen
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2188096656
